Icu Medical (ICUI) EBIT Growth (3y) (2012 - 2026)
Powered by 
Analysis
Icu Medical (ICUI) EBIT Growth (3y) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 177.43 Bn | 172.48 Bn | 7.27 Bn | 3.16% |
| 2 | Intuitive Surgical | 139.20 Bn | 134.11 Bn | 1.96 Bn | 28.02% |
| 3 | Medtronic | 118.01 Bn | 109.81 Bn | 6.34 Bn | 11.63% |
| 4 | Stryker | 105.44 Bn | 101.96 Bn | 4.50 Bn | 19.80% |
| 5 | Boston Scientific | 62.90 Bn | 62.60 Bn | 3.85 Bn | 31.84% |
| 6 | Edwards Lifesciences | 50.87 Bn | 46.72 Bn | 1.35 Bn | 24.88% |
| 7 | Dexcom | 33.72 Bn | 31.77 Bn | 830.00 Mn | 35.44% |
| 8 | Resmed | 32.45 Bn | 30.98 Bn | 861.22 Mn | 17.69% |
| 9 | Alcon | 31.70 Bn | 30.25 Bn | 1.68 Bn | -65.59% |
| 10 | Icu Medical | 3.82 Bn | 3.52 Bn | 235.05 Mn | 142.02% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 142.02% |
| Mar 31, 2026 | 13.06% |
| Dec 31, 2025 | 201.41% |
| Sep 30, 2025 | 215.41% |
| Jun 30, 2025 | 506.02% |
| Mar 31, 2025 | 32.11% |
| Dec 31, 2024 | 16.52% |
| Sep 30, 2024 | -40.13% |
| Jun 30, 2024 | -39.35% |
| Mar 31, 2024 | -33.91% |
| Dec 31, 2023 | -34.83% |
| Sep 30, 2023 | -3.63% |
| Jun 30, 2023 | -47.94% |
| Mar 31, 2023 | -28.83% |
| Dec 31, 2022 | -26.25% |
| Sep 30, 2022 | -26.29% |
| Jun 30, 2022 | -26.03% |
| Mar 31, 2022 | -50.19% |
| Dec 31, 2021 | 66.42% |
| Sep 30, 2021 | 157.27% |